Kanvas Biosciences
Business Services · New Jersey, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1 Deerpark Dr Ste G5, Monmouth Junction,...Phone Number
(617) 435-4900Website
www.kanvasbio.comRevenue
$10.4 MillionIndustry
ZI Rank: 2
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
2
1
1
1
2
About Kanvas Biosciences
Kanvas Biosciences is a spatial biology company building the worlds first microbiome drug screening, discovery and manufacturing platform to accelerate the development of next generation live biotherapeutics. With an unparalleled ability to spatially map the microbiome and profile host gene expression, and manufacture complex consortia containing hundreds of members that can restore microbiome health, the company is uniquely positioned to develop novel therapeutics that can significantly improve the lives of all patients living with microbiome-associated diseases. Kanvas Biosciences' technology was initially developed at Cornell University and exclusively licensed. The company's notable investors include DCVC, Lions Capital LLC, Gates Foundation, ATHOS KG, FemHealth Ventures, Germin8, Ki Tua Fund, Pangaea Ventures, Triple Impact Capital and Uncommon Denominator. Kanvas Biosciences is headquartered in Princeton, New Jersey.Explore more
Kanvas Biosciences Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kanvas Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Kanvas Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Kanvas Biosciences has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Kanvas Biosciences launches new products
Check out if Kanvas Biosciences is spiking on competitors!
Click to see if Kanvas Biosciences had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kanvas Biosciences
Funding: Get notified immidiatlly once Kanvas Biosciences has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Kanvas Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Kanvas Biosciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to Kanvas Biosciences
Compare insights from companies similar to Kanvas Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kanvas Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kanvas Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kanvas Biosciences.
Kanvas Biosciences financials insights
Gather financial insights about Kanvas Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$3.9M
Seed
$24.5M
2026
Series A
$48M
Kanvas Biosciences Tech Stack
A closer look at the technologies used by Kanvas Biosciences
Most Recent Scoops
Open Position
Funding
Funding
Funding
Funding
Funding
Funding
New Hire
Executive Move
Kanvas Biosciences News & Media
Kanvas Bio Publishes New Research on its Novel Spectral Imaging Platform, a Transformative Tool for Microbiome Drug Discovery and Development
In the paper, Kanvas demonstrates that its technology outperforms conventional sequencing, achieving a sensitivity of 0.01% and enabling species-level microbial identification. PRINCETON, N.J., April 1, 2025 /PRNewswire/ -- Kanvas Biosciences, a full-stack spatial biology company, today...Human Microbiome Market Size to Surge to $4.85 Billion by 2031, Fuelled by Research and Innovation - Exclusive Report by The Insight Partners
The human microbiome market share is expected to reach US$ 4.85 billion by 2031, driven by increased investments in research, therapeutics, and diagnostics. North America leads the market, with the Asia Pacific region projected to see the highest growth The human microbiome market share is expected to reach US$ 4.85 billion by 2031, driven by increased investments in research, therapeutics, and diagnostics. North America leads the market, with the Asia Pacific region projected to seeKanvas Bio Unveils Clinical Data on the Gut Microbiome’s Impact on Anti-Tumoral Immunity at SITC
PRINCETON, N.J.--(BUSINESS WIRE)--Kanvas Biosciences, a full-stack spatial biology company, today announced results from a clinical trial of fecal microbiota transplantation (FMT) and anti-PD-1 re-induction in microsatellite instability-high (MSI-H) refractory cancers. Presented at the third annual Society for Immunotherapy of Cancer (SITC) meeting, the trial data show that FMT enabled a response to reintroduced anti-PD-1 in patients with anti-PD-1 refractory, MSI-H cancers, and suggest that thKanvas Biosciences Secures Additional $12.5M in Funding
Kanvas Biosciences, Princeton, NJ-based spatial biology company, raised additional $12.5M in funding. The round, which brought the total amount to $29.5M, was led by DCVC and Lions Capital LLC, and participation from FemHealth Ventures, Germin8, Ki Tua Fund, and Pangaea Ventures as well as existing investors. Paul Theunissen, Managing Partner at Lions Capital Partners LLC, will join the company’s Board, and Ashlie L […] The post Kanvas Biosciences Secures Additional $12.5M in Funding appeared fi
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kanvas Biosciences
Sign Up For FreeTo access detailed company insights
Kanvas Biosciences is a spatial biology company building the worlds first microbiome drug screening, discovery and manufacturing platform to accelerate the development of next generation live biotherapeutics. With an unparalleled ability to spatially map the microbiome and profile host gene expression, and manufacture complex consortia containing h... Read More
